[1] Boycott KM, Rath A, Chong JX, et al. International coo-peration to enable the diagnosis of all rare genetic di-seases[J]. Am J Hum Genet,2017,100(5):695-705.
[2] 钱欣, 罗玉琴, 徐晓姹, 等. 2619例高龄孕妇羊水细胞染色体核型分析[J]. 中华医学遗传学杂志,2009,26(6):712-713.
[3] 张鼎, 胡小梅, 胡爱武. 荧光原位杂交技术及其在遗传学中的应用进展[J]. 中华全科医学,2010,8(6):762-764.
[4] Shen Y, Wu BL. Microarray-based genomic DNA profi-ling technologies in clinical molecular diagnostics[J]. Clin Chem,2009,55(4):659-669.
[5] Hu L, Yao X, Huang H, et al. Clinical significance of germline copy number variation in susceptibility of human diseases[J]. J Genet Genomics,2018,45(1):3-12.
[6] Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification[J]. Nucleic Acids Res,2002,30(12):e57.
[7] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors[J]. Proc Natl Acad Sci U S A,1977,74(12):5463-5467.
[8] Hehir-Kwa JY, Claustres M, Hastings RJ, et al. Towards a European consensus for reporting incidental findings during clinical NGS testing[J]. Eur J Hum Genet,2015, 23(12):1601-1606.
[9] Meienberg J, Bruggmann R, Oexle K, et al. Clinical sequencing: is WGS the better WES?[J]. Hum Genet,2016,135(3):359-362.
[10] Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med,2016,18(7):696-704.
[11] Caspar SM, Dubacher N, Kopps AM, et al. Clinical sequencing: From raw data to diagnosis with lifetime value[J]. Clin Genet,2018,93(3):508-519.
[12] Byron SA, van Keuren-Jensen KR, Engelthaler DM, et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges[J]. Nat Rev Genet,2016,17(5):257-271.
[13] Kremer LS, Wortmann SB, Prokisch H. "Transcriptomics": molecular diagnosis of inborn errors of metabolism via RNA-sequencing[J/OL]. Inherit Metab Dis,2018-01-25[2018-03-19]. https://www.ncbi.nlm.nih.gov/pubmed/29372369.
[14] Kimble DC, Lach FP, Gregg SQ, et al. A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families[J]. Hum Mutat,2018,39(2):237-254.
[15] Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet,2010,86(5):749-764.
[16] Hu X, Li N, Xu Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience[J/OL]. Genet Med,2017-11-02[2018-03-19].https://www.ncbi.nlm.nih.gov/pubmed/29095814.
[17] Alfares A, Aloraini T, Subaie LA, et al. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing[J/OL]. Genet Med,2018-03-22[2018-04-09].https://www.ncbi.nlm.nih.gov/pubmed/29565419.
[18] Posey JE, Harel T, Liu P, et al. Resolution of disease phenotypes resulting from multilocus genomic variation[J]. N Engl J Med,2017,376(1):21-31.
[19] Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics[J]. Genet Med,2017,19(2):249-255.
[20] Kearney HM, Thorland EC, Brown KK, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants[J]. Genet Med,2011,13(7):680-685.
[21] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med,2015,17(5):405-424.
[22] National Society of Genetic Counselors' Definition Task Force, Resta R, Biesecker BB, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report[J]. J Genet Couns,2006,15(2):77-83.
[23] Tarailo-Graovac M, Shyr C, Ross CJ, et al. Exome sequencing and the management of neurometabolic disorders[J]. N Engl J Med,2016,374(23):2246-2255. |
